参　考　文　献

1　Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. BullWorld Health Organ,1984, 62: 1632182.

2　El2Serag HB. Ep idemiology of hepatocellular carcinoma. Clin L iverDis, 2001, 5: 872107.

3　L iu CJ , Kao JH. Hepatitis B virus2related hepatocellular carcinoma: ep idemiology and pathogenic role of viral factors. J ChinMed Assoc, 2007, 70: 1412145.

4　Vallet S, Gouriou S, Nkontchou G, et al. Is hepatitis C virus NS3 p rotease quasispecies heterogeneity p redictive of p rogressionfrom cirrhosis to hepatocellular carcinoma? J Viral Hepat, 2007, 14: 962106.

5　Su PF, Lee TC, L in PJ , et al. DifferentialDNA methylation associated with hepatitis B virus infection in hepatocellular carcino2ma. Int J Cancer, 2007, 121: 125721264.

6　FeitelsonMA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett, 2007, 252: 1572170.

7　Lupberger J , Hildt E. Hepatitis B virus2induced oncogenesis. World J Gastroenterol, 2007, 13: 74281.

8　Zhu R, L i BZ, L ing YQ, et al. Chronic hepatitis B virus infection and the methylation status of p16 INK4A p romoter. ZhonghuaZhong L iu Za Zhi, 2007, 29: 1662170.

9　Zhu R, L i BZ, L i H, et al. Association of p16 INK4A hypermethylation with hepatitis B virus X p rotein exp ression in the earlystage of HBV2associated hepatocarcinogenesis. Pathol Int, 2007, 57: 3282336.

10　Chou YC, YuMW, Wu CF, et al. Temporal relationship between hepatitisB virus enhancer II/basal core p romoter sequence var2iation and risk of hepatocellular carcinoma. Gut, 2008, 57: 91297.

11　ShinkaiN, Tanaka Y, Ito K, et al. Influence of hepatitis B virus X and core p romotermutations on hepatocellular carcinoma a2mong patients infected with subgenotype C2. J ClinMicrobiol, 2007, 45: 319123197.

12　Orito E, MizokamiM. Differences of HBV genotypes and hepatocellular carcinoma in Asian countries. Hepatol Res, 2007, 37:S33235.

13　YuenMF, Tanaka Y, ShinkaiN, et al. Risk for hepatocellular carcinoma with respect to hepatitisB virus genotypesB /C, specif2ic mutations of enhancer II/ core p romoter/p recore regions and HBV DNA levels. Gut, 2008, 57: 982102.

14　L in CL, L iu CH, ChenW, et al. Association of p re2S deletion mutant of hepatitis B viruswith risk of hepatocellular carcinoma.J Gastroenterol Hepatol, 2007, 22: 109821103.

15　Muroyama R, Kato N, Yoshida H, et al. Nucleotide change of codon 38 in the X gene of hepatitisB virus genotype C is associat2ed with an increased risk of hepatocellular carcinoma. J Hepatol, 2006, 45: 8052812.

16　Lee AT, Lee CG. Oncogenesis and transforming viruses: the hepatitis B virus and hepatocellular carcinoma 22the etiopathogeniclink. Front Biosci, 2007, 12: 2342245.

17　Pang R, Lee TK, Poon RT, et al. Pin1 interactswith a specific serine2p rolinemotif of hepatitisB virus X2p rotein to enhance hep2atocarcinogenesis. Gastroenterology, 2007, 132: 108821103.

18　ZhouW, Shen Q, Gu B, et al. Effects of hepatitisB virus X gene on apop tosis and the activity of telomerase in HepG(2) cells. Zhonghua Gan Zang Bing Za Zhi, 2000, 8: 2122214.

19　TamoriA, Yamanishi Y, Kawashima S, et al. Alteration of gene exp ression in human hepatocellular carcinoma with integratedhepatitis B virusDNA. Clin Cancer Res, 2005, 11: 582125826.

20　Kojima H, Kaita KD, Xu Z, et al. The absence of up2regulation of telomerase activity during regeneration after partial hepatecto2
my in hepatitis B virus X gene transgenic mice. J Hepatol, 2003, 39: 2622268.

21　Hussain SP, Schwank J , Staib F, et al. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesisof liver cancer. Oncogene, 2007, 26: 216622176.

22　L i H, Chi CY, Lee S, et al. The mitogenic function of hepatitis B virus X p rotein resides within amino acids 51 to 140 and ismodulated by N2 and C2terminal regulatory regions. J Virol, 2006, 80: 10554210564.

23　Ou DP, Tao YM, Tang FQ, et al. The hepatitisB virus X p rotein p romotes hepatocellular carcinomametastasis by up regulation ofmatrix metallop roteinases. Int J Cancer, 2007, 120: 12082214.

24　Park IY, Sohn BH, Yu E, et al. Aberrant ep igenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X p ro2tein. Gastroenterology, 2007, 132: 147621494.

25　Kremer2Tal S, Narla G, Chen Y, et al. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates p rolif2eration while reducing differentiation. J Hepatol, 2007, 46: 6452654.

26　Yao DF, Wu XH, Su XQ, et al. Abnormal exp ression of HSP gp96 associated with HBV rep lication in human hepatocellular car2cinoma. Hepatobiliary PancreatDis Int, 2006, 5: 3812386.

27　Zheng Y, ChenWL, Louie SG, et al. HepatitisB virus p romotes hepatocarcinogenesis in transgenic mice. Hepatology, 2007, 45:16221.

(收稿日期: 2008201203)
(本文编辑:温少芳)